{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:28:24Z","timestamp":1765279704406,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.cgh.2010.01.022","type":"journal-article","created":{"date-parts":[[2010,2,13]],"date-time":"2010-02-13T04:41:10Z","timestamp":1266036070000},"page":"458-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Reduction of Insulin Resistance With Effective Clearance of Hepatitis C Infection: Results From the HALT-C Trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Aymin","family":"Delgado\u2013Borrego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio H.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betania","family":"Negre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Kamegaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle","family":"Christofi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna S.F.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2010.01.022_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2004.03.020","article-title":"Insulin resistance and insulin secretion in chronic hepatitis C virus infection","volume":"41","author":"Narita","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.01.022_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/01.TP.0000114283.04840.3A","article-title":"Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation","volume":"77","author":"Delgado-Borrego","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2010.01.022_bib3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2010.01.022_bib4","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression","volume":"125","author":"Hui","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.01.022_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/lt.21267","article-title":"Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance","volume":"14","author":"Delgado-Borrego","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2010.01.022_bib6","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3","volume":"165","author":"Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cgh.2010.01.022_bib7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.01.022_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cct.2004.08.003","article-title":"Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders","volume":"25","author":"Lee","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2010.01.022_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cgh.2006.11.002","article-title":"Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis trial","volume":"5","author":"Lok","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2010.01.022_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1309\/42D6-W7PL-FX0A-LBXF","article-title":"Pathologic features of chronic hepatitis: a review and update","volume":"113","author":"Ishak","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cgh.2010.01.022_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/JCM.41.2.651-656.2003","article-title":"Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA","volume":"41","author":"Hendricks","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cgh.2010.01.022_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jcem-44-4-681","article-title":"Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism","volume":"44","author":"Hayashi","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cgh.2010.01.022_bib13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cgh.2010.01.022_bib14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.21265","article-title":"HCV RNA detection by TMA during the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial","volume":"44","author":"Morishima","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2010.01.022_bib15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-Gomez","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.01.022_bib16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1572-0241.2006.01038.x","article-title":"Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2","volume":"102","author":"Kawaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.01.022_bib17","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1152\/ajpendo.00494.2003","article-title":"Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics","volume":"287","author":"Tietge","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cgh.2010.01.022_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2796.2005.01543.x","article-title":"Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis","volume":"258","author":"Kaser","year":"2005","journal-title":"J Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2010.01.022_bib19","first-page":"315","article-title":"Glucose intolerance caused by interferon therapy","volume":"63","author":"Kanai","year":"2005","journal-title":"Nippon Rinsho"},{"issue":"Suppl 7","key":"10.1016\/j.cgh.2010.01.022_bib20","first-page":"760","article-title":"Glucose intolerance induced by interferon therapy","volume":"60","author":"Sasaoka","year":"2002","journal-title":"Nippon Rinsho"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356510001448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356510001448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:05:12Z","timestamp":1761541512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356510001448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1542356510001448"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2010.01.022","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of Insulin Resistance With Effective Clearance of Hepatitis C Infection: Results From the HALT-C Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2010.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}